Doubts about psychedelics from Albert Hofmann, LSD’s discoverer
September 24th, 2010 |
18

Psychedelics are back! As readers of Scientific American know, scientists have recently reported that psychedelics show promise for treating disorders such as depression, post-traumatic stress disorder, and anxiety in terminal cancer patients. This weekend, researchers and other enthusiasts are gathering in New York City for a two-day celebration, "Horizons: Perspectives on Psychedelics," sponsored by the [...]
Keep reading »Overprescribing the Healthy Elderly: Why Funding Research and Drug Safety Is Paramount
June 30th, 2011 |
10

My frail, 92-year-old mother was prescribed 80 mgs of the cholesterol-lowering drug, or statin, simvastatin for years. She fell four times in the last four years of her life: the last fall was the least forgiving. Doctors diagnosed her with rhabdomyolysis, a life-threatening condition, and acute kidney failure; she was dead within 8 weeks. Source: [...]
Keep reading »Pharmacies Dispense Meds Even after Docs Stop Prescription
November 19th, 2012 |
6

When doctors take patients off of a prescription medicine, it is often for a good reason. But pharmacists don’t always get the memo. A new study finds that more than 1 in 100 discontinued prescriptions were filled by the pharmacy anyway, putting some patients at serious risk. In the U.S., pharmacists filled more than 3.7 [...]
Keep reading »1 in 5 Rx’s for Seniors Is Inappropriate
August 22nd, 2012 |
3

Take two of these—or should that be three? Or one? Congress recently took steps to improve the safety of children’s drugs. Now, a new study finds that those on the other end of the age spectrum also frequently receive medication that may put their health at risk. Approximately 20 percent of prescriptions that primary care [...]
Keep reading »Better Living Through Chemistry: Making Sudafed from Meth
February 29th, 2012 |
3

April is coming and, with its approach, the latest publication from one of the most prolific synthetic chemists anywhere has just appeared. Forget esoteric technologies like small hairpin RNAs. With this entry into the literature, chemists finally have something useful to work on again. Their expertise and ingenuity can pragmatically address a specific instance of [...]
Keep reading »Smoke and Mirrors: Driving While High on Marijuana Doubles One’s Chances of a Serious Car Crash
February 9th, 2012 |
26

Booze is behind an estimated 2.1 million car accidents each year in the U.S.—which cause almost 11,000 traffic fatalities annually. But many drug users have claimed that a few puffs of pot before getting behind the wheel are perfectly harmless. A new study, however, shows that drivers who smoke marijuana within a few hours of [...]
Keep reading »Missing Medical Data Could Harm Patients
January 4th, 2012 |
4

Big clinical trials—to test new drugs or procedures—generate reams of important data about safety and efficacy. Only a fraction of that information sees the light of day, a publishing practice that could put patients at risk, according to a special report published this week in the British Medical Journal (BMJ). Even though scientific and medical [...]
Keep reading »Health Care Needs (More) Reform: Cancer Drugs Show How Markets Remain out of Whack
September 13th, 2011 |
5
The market for at least one class of vital drug seems to have gone haywire. Certain types of generic cancer drugs are really hard to find. In August, of the 34 generic cancer drugs available to patients, there were 14 that could only be found with great difficulty. “If you are a pediatric oncologist, you [...]
Keep reading »How much money was your doctor paid by a drug company?
October 21st, 2010 |
3

It’s no secret that many doctors get paid by pharmaceutical companies to talk to other docs—about general conditions, research trends or specific drugs—or to provide expertise for company research. But what has long been undisclosed is the amount of money that these drugmakers were giving physicians for their time. Thanks in part to some high-profile [...]
Keep reading »Your love is my drug: How passion sparks the same painkilling pathways as drugs
October 14th, 2010 |
8
.jpg)
Who says love hurts? New research shows that strong romantic feelings actually ease physical pain via the same neural pathways as powerful drugs. By simply gazing at a picture of their beloved, undergraduates in a recent study were able to substantially reduce their experience of pain. The effect occurs thanks to a boost in the [...]
Keep reading »Diabetes drug investigation yields unclear decision from FDA committee
July 15th, 2010 |
1
.jpg)
This week, a federal advisory committee of 33 experts convened to review data on the controversial type 2 diabetes drug, Avandia, and debated whether the drug should remain on the market. The meeting was prompted by recent studies suggesting that patients on the drug have an increased risk of heart attack. The U.S. Food and [...]
Keep reading »FDA Enlists Big Data to Track Down Pharma Fraud
June 4th, 2013 |
1

Predictive analytics—lumped under the faddish banner of Big Data—is the high-profile set of techniques that tame numeric deluges to deduce that a new epidemic is starting to break or that a last-minute steal of an airfare has just popped up. The best uses for Big D may be yet to come, though. The FDA just [...]
Keep reading »The Grand Challenge of Schizophrenia Drugs
September 21st, 2012 |
1

A milestone for Big Neuroscience came Wednesday with the publication in Nature of a study on the way genes switch on across the whole human brain. Whole brain is all the vogue. Neuroscientists have devoted inordinate energy in recent years to publicize the need for, not only gene maps, but for a full wiring diagram [...]
Keep reading »Office Parties Are Just Like Four Loko (Which Is Just Like The Copenhagen Philharmonic)

When this headline from The Telegraph flashed across Google Reader, I couldn’t help but be amused: Scientists explain why the office party so often ends in embarrassment. From the article: Now scientists have come up with an explanation for why the office party is so often the cause of embarrassing and inappropriate behaviour. Researchers have [...]
Keep reading »Four Loko Is Just Like The Copenhagen Philharmonic

It’s an ordinary afternoon at Copenhagen Central Station. At 2:32pm, a man who appears to be a run-of-the-mill street performer sets up a drum in the center of a large hall. A cellist joins him. A woman approaches with her flute. The melody is sort of recognizable… It sounds sort of like Ravel’s Bolero. Pretty [...]
Keep reading »



![journal.pone.0065275.g001 Figure 1. Plot of the locations of the languages in the sample. Dark circles represent languages with ejectives, clear circles represent those without ejectives. Clusters of languages with ejectives are highlighted with white rectangles. For illustrative purposes only. Inset: Lat-long plot of polygons exceeding 1500 m in elevation. Adapted from Figure 4 in [8]. The six major inhabitable areas of high elevation are highlighted via ellipses: (1) North American cordillera (2) Andes (3) Southern African plateau (4) East African rift (5) Caucasus and Javakheti plateau (6) Tibetan plateau and adjacent regions. doi:10.1371/journal.pone.0065275.g001](http://blogs.scientificamerican.com/anthropology-in-practice/wp-content/blogs.dir/8/files/2013/06/journal.pone_.0065275.g0011.png)




See what we're tweeting about



